VOSEVI is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have [see Dosage and Administration (2.2) and Clinical Studies (14)]:

VOSEVI is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis who have: • genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen

Aug 23, 2023 · Vosevi (sofosbuvir,velpatasvir and voxilaprevir) is used to treat chronic hepatitis C. Includes Vosevi side effects, interactions and indications.

Mar 25, 2024 · VOSEVI is a fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, velpatasvir, an HCV NS5A inhibitor, and voxilaprevir, an HCV NS3/4A protease inhibitor, and is indicated for the treatment of adult patients with chronic HCV infection without cirrhosis or with compensated cirrhosis (Child ...

The recommended dosage of VOSEVI is one tablet, taken orally, once daily with food. One tablet of VOSEVI contains 400 mg of sofosbuvir, 100 mg of velpatasvir, and 100 mg of voxilaprevir. Table 1 shows the recommended treatment regimen and duration based on patient population.

Apr 4, 2024 · Vosevi (sofosbuvir/velpatasvir/voxilaprevir) is a brand-name drug prescribed for chronic hepatitis C in adults in certain situations. Vosevi comes as an oral tablet that’s typically taken...

Medscape - Hepatitis C dosing for Vosevi (sofosbuvir/velpatasvir/voxilaprevir), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules,...

Vosevi is an antiviral medicine used to treat chronic hepatitis C, an long-term infection of the liver caused by the hepatitis C virus (HCV), in patients aged 12 and older, weighing at least 30 kg. Vosevi contains the active substances sofosbuvir, velpatasvir and …

Apr 6, 2022 · Vosevi is a combination of three antiviral medications: sofosbuvir, velpatasvir, and voxilaprevir. It's one of the first-choice treatments for people who've been treated but not cured of hepatitis C, an infection caused by the hepatitis C virus (HCV) in the liver. This medication is only taken once a day, but can sometimes cause headaches.

HCV treatment with VOSEVI. In patients with serologic evidence of HBV infection, monitor for clinical and laboratory signs of hepatitis flare or HBV reactivation during HCV treatment with VOSEVI and during post-treatmen.